Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation

Clinical and Experimental Immunology

Volumn 131, Issue 1, 2003, Pages 102-110

  Hohn H ^c   Julch M ^c   Pilch, H ^a   Kortsik, C ^b   Tully, G ^c   Neukirch, C ^c   Freitag, K ^c   Maeurer, Markus ^c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b St Hildegardis Krankenhaus   (Germany)

^c Hochhaus am Augustusplatz ^*

Author keywords

CD8+ T cells; HPV; M. tuberculosis; MHC; Tetramer

Indexed keywords

BACTERIAL ANTIGEN; CD28 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GENE PRODUCT; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR RECOGNITION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UTERINE CERVIX DISEASE; VIRUS INFECTION; WART VIRUS;

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, BACTERIAL; ANTIGENS, CD28; ANTIGENS, CD45; BACTERIAL PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; MYCOBACTERIUM TUBERCULOSIS; PAPILLOMAVIRUS INFECTIONS; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, PULMONARY; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

EID: 12244293433     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02036.x     Document Type: Article

References (31)

1. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272:54-60.
2. + T cells. J Exp Med 1997; 186:1407-18.
3. Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274:94-6.
4. McMichael AJ, O'Callaghan CA. A new look at T cells. J Exp Med 1998; 187:1367-71.
5. Kast WM, Feltkamp MC, Ressing ME, Vierboom MP, Brandt RM, Melief CJ. Cellular immunity against human papillomavirus associated cervical cancer. Semin Virol 1996; 7:117-23.
6. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
7. + T cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1. Int J Cancer 2002; 98:376-88.
8. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426-32.
9. + T cells enables preservation of a naive repertoire. J Immunol 1998; 161:5909-17.
10. + T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis 2000; 182:451-8.
11. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
12. Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8 (+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63-75.
13. Chen G, Shankar P, Lange C et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001; 98:156-64.
14. Westermann J, Pabst R. Lymphocyte subsets in the blood, a diagnostic window on the lymphoid system? Immunol Today 1990; 11:406-10.
15. Lee KH, Panelli MC, Kim CJ et al. Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J Immunol 1998; 161:4183-94.
16. Gomez A, Bourgault I, Gomard E, Picard F, Levy JP. Role of different lymphocyte subsets in human anti-viral T cell cultures. Cell Immunol 1989; 118:312-27.
17. + T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol 1999; 162:7569-77.
18. Kono K, Ressing ME, Brandt RM et al. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996; 2:1825-8.
19. Santin AD, Hermonat PL, Ravaggi A et al. Induction of human papillomavirus-specific CD4 (+) and CD8 (+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J Virol 1999; 73:5402-10.
20. + cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Clin Cancer Res 2001; 7:804s-10s.
21. + T cells after vaccination with antigenic peptide. Clin Cancer Res 2001; 7:796s-803s.
22. Seitzer U, Kayser K, Hohn H et al. Reduced T cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection. Immunology 2001; 104:269-77.
23. Zea AH, Ochoa MT, Ghosh P et al. Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun 1998; 66:499-504.
24. Ressing ME, Sette A, Brandt RM et al. Human CTL epitopes encoded by human papillomavirus type 16, E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 1995; 154:5934-43.
25. Kast WM, Brandt RM, Sidney J et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16, E6 and E7 proteins. J Immunol 1994 152: 3904-12.
26. Champagne P, Ogg GS, King AS et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.
27. Bercovici N, Duffour MT, Agrawal S, Salcedo M, Abastado JP. New methods for assessing T cell responses. Clin Diagn Laboratory Immunol 2000; 7:859-64.
28. Van Der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 1996; 156:3308-14.
29. Mohagheghpour N, Gammon D, Kawamura LM, Van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998; 161:2400-6.
30. + CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 2000; 165:7088-95.
31. + T cells in HLA- transgenic mice and humans. J Immunol 2000; 165:6463-71.